Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy

被引:8
|
作者
Yang, Xiaolin [1 ]
Zhang, Xiaoqing [1 ]
Shen, Kaifeng [1 ]
Wang, Zhongke [2 ]
Liu, Guolong [1 ]
Huang, Kaixuan [1 ]
He, Zeng [1 ]
Li, Yang [1 ]
Hou, Zhi [1 ]
Lv, Shengqing [1 ]
Zhang, Chunqing [1 ,3 ]
Yang, Hui [1 ,3 ]
Liu, Shiyong [1 ,3 ]
Ke, Yanyan [1 ]
机构
[1] Army Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing, Peoples R China
[2] Armed Police Hosp, Dept Neurosurg, Chongqing, Peoples R China
[3] Chongqing Inst Brain & Intelligence, Guangyang Bay Lab, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
cuproptosis; Fdx1; LIPT1; temporal lobe epilepsy; diagnostic indicator; immune microenvironment; HIPPOCAMPAL SCLEROSIS; CELL-DEATH; COPPER; MICE; DEFICIENCY; METABOLISM; INDUCE;
D O I
10.3389/fphar.2023.1033859
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Temporal lobe epilepsy (TLE) is the most common subtype of epilepsy in adults and is characterized by neuronal loss, gliosis, and sprouting mossy fibers in the hippocampus. But the mechanism underlying neuronal loss has not been fully elucidated. A new programmed cell death, cuproptosis, has recently been discovered; however, its role in TLE is not clear.Methods: We first investigated the copper ion concentration in the hippocampus tissue. Then, using the Sample dataset and E-MTAB-3123 dataset, we analyzed the features of 12 cuproptosis-related genes in TLEs and controls using the bioinformatics tools. Then, the expression of the key cuproptosis genes were confirmed using real-time PCR and immunohistochemical staining (IHC). Finally, the Enrichr database was used to screen the small molecules and drugs targeting key cuproptosis genes in TLE.Results: The Sample dataset displayed four differentially expressed cuproptosis-related genes (DECRGs; LIPT1, GLS, PDHA1, and CDKN2A) while the E-MTAB-3123 dataset revealed seven DECRGs (LIPT1, DLD, FDX1, GLS, PDHB, PDHA1, and DLAT). Remarkably, only LIPT1 was uniformly upregulated in both datasets. Additionally, these DECRGs are implicated in the TCA cycle and pyruvate metabolism-both crucial for cell cuproptosis-as well as various immune cell infiltrations, especially macrophages and T cells, in the TLE hippocampus. Interestingly, DECRGs were linked to most infiltrating immune cells during TLE's acute phase, but this association considerably weakened in the latent phase. In the chronic phase, DECRGs were connected with several T-cell subclasses. Moreover, LIPT1, FDX1, DLD, and PDHB were related to TLE identification. PCR and IHC further confirmed LIPT1 and FDX1's upregulation in TLE compared to controls. Finally, using the Enrichr database, we found that chlorzoxazone and piperlongumine inhibited cell cuproptosis by targeting LIPT1, FDX1, DLD, and PDHB.Conclusion: Our findings suggest that cuproptosis is directly related to TLE. The signature of cuproptosis-related genes presents new clues for exploring the roles of neuronal death in TLE. Furthermore, LIPT1 and FDX1 appear as potential targets of neuronal cuproptosis for controlling TLE's seizures and progression.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
    Cui, Yuting
    Chen, Yanyu
    Gan, Ni
    Li, Man
    Liao, Wei
    Zhou, Yating
    Xiang, Qiong
    Gong, Xi
    Guo, Qianqian
    Hu, Pengwei
    Zheng, Xi-Long
    Shang, Desi
    Peng, Juan
    Tang, Zhihan
    MOLECULAR BIOMEDICINE, 2023, 4 (01):
  • [2] A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
    Li, Yaoting
    Zeng, Xuezhen
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [3] A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
    Yuting Cui
    Yanyu Chen
    Ni Gan
    Man Li
    Wei Liao
    Yating Zhou
    Qiong Xiang
    Xi Gong
    Qianqian Guo
    Pengwei Hu
    Xi-Long Zheng
    Desi Shang
    Juan Peng
    Zhihan Tang
    Molecular Biomedicine, 4
  • [4] Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer
    Liu, Yanqing
    Liu, Yang
    Ye, Shujun
    Feng, Huijin
    Ma, Lianjun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Identification and verification of a novel signature that combines cuproptosis-related genes with ferroptosis-related genes in osteoarthritis using bioinformatics analysis and experimental validation
    He, Baoqiang
    Liao, Yehui
    Tian, Minghao
    Tang, Chao
    Tang, Qiang
    Ma, Fei
    Zhou, Wenyang
    Leng, Yebo
    Zhong, Dejun
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [6] Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma
    Zhang, Bingxin
    Wang, Quanqiang
    Zhang, Tianyu
    Zheng, Ziwei
    Lin, Zhili
    Zhou, Shujuan
    Zheng, Dong
    Chen, Zixing
    Zheng, Sisi
    Zhang, Yu
    Lin, Xuanru
    Dong, Rujiao
    Chen, Jingjing
    Qian, Honglan
    Hu, Xudong
    Zhuang, Yan
    Zhang, Qianying
    Jin, Zhouxiang
    Jiang, Songfu
    Ma, Yongyong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [7] Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
    Liu, Xiangdong
    Luo, Bo
    Wu, Xinhong
    Tang, Zijian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (06):
  • [8] A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
    Bian, Zilong
    Fan, Rong
    Xie, Lingmin
    GENES, 2022, 13 (05)
  • [9] Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma
    Guo, Ding-Fan
    Fan, Lin-Wei
    Zeng, Hai-Hui
    Huang, Cai-Bin
    Wu, Xin-Huan
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (02) : 739 - 764
  • [10] The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
    Zhao, Xueying
    Chen, Jin
    Yin, Shangqi
    Shi, Jingren
    Zheng, Mei
    He, Chaonan
    Meng, Huan
    Han, Ying
    Han, Jinyu
    Guo, Jingjing
    Yuan, Zhengrong
    Wang, Yajie
    FRONTIERS IN ONCOLOGY, 2022, 12